Risk Factors for Reoperation After Arterial Switch Operation.


Journal

World journal for pediatric & congenital heart surgery
ISSN: 2150-136X
Titre abrégé: World J Pediatr Congenit Heart Surg
Pays: United States
ID NLM: 101518415

Informations de publication

Date de publication:
07 2021
Historique:
entrez: 19 7 2021
pubmed: 20 7 2021
medline: 19 2 2022
Statut: ppublish

Résumé

The timing and nature of and risk factors for reoperation after the arterial switch operation in the setting of d-transposition of the great arteries requires further elucidation. A total of 403 patients who underwent arterial switch operation from 1986 to 2017 were reviewed. Institutional preference was for pulmonary artery reconstruction using a pantaloon patch of fresh autologous pericardium. The targets for coronary artery reimplantation were identified by intermittent root distension. Multivariable analysis was used to identify risk factors for reoperation. Median follow-up was 8.6 years (interquartile range [IQR]: 2-16.9). Pulmonary arterioplasty was the most common reoperation (n = 11, 2.7%) at 3.3 years (IQR: 1.4-11.4) postoperatively. Subvalvar right ventricular outflow tract reconstruction (RVOTR) was required in nine (2.2%) patients at 2.5 years (IQR: 1.1-5.3) postoperatively. Aortic valve repair or replacement (AVR/r) was required in seven (1.7%) patients at 13.6 years (IQR: 10.0-15.8) postoperatively. Aortic root replacement (ARR) and Coronary Artery Bypass Graft/coronary patch arterioplasty were required in five (1.2%) patients each at 13.6 years (IQR: 11.0-15.3) and 11.3 years (IQR: 2.3-13.6) postoperatively, respectively. Taussig-Bing anomaly was a risk factor for any reoperation ( Pantaloon patch pulmonary artery reconstruction and intermittent neo-aortic root distension during coronary reimplantation have minimized respective outflow tract reoperations. Certain anatomic subsets carry different risks for late reoperation, and pulmonary artery and/or RVOT reinterventions tend to occur sooner than aortic reinterventions. Special attention to these higher risk subpopulations will be critical to optimizing lifelong outcomes.

Identifiants

pubmed: 34278862
doi: 10.1177/21501351211009768
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-470

Auteurs

Parth M Patel (PM)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.
* These two authors contributed equally to this work.

Jeremy L Herrmann (JL)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.
22536Riley Children's Health at Indiana University Health, Indianapolis, IN, USA.
* These two authors contributed equally to this work.

Eric Bain (E)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.

Joseph M Ladowski (JM)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.

Cameron Colgate (C)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.

Mark D Rodefeld (MD)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.
22536Riley Children's Health at Indiana University Health, Indianapolis, IN, USA.

Mark W Turrentine (MW)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.
22536Riley Children's Health at Indiana University Health, Indianapolis, IN, USA.

John W Brown (JW)

Division of Thoracic and Cardiovascular Surgery, 12250Indiana University School of Medicine, Indianapolis, IN, USA.
22536Riley Children's Health at Indiana University Health, Indianapolis, IN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH